Minimizing inequality in access to precision medicine in breast cancer by real‐time population‐based molecular analysis in the SCAN‐B initiative

BACKGROUND: Selection of systemic therapy for primary breast cancer is currently based on clinical biomarkers along with stage. Novel genomic tests are continuously being introduced as more precise tools for guidance of therapy, although they are often developed for specific patient subgroups. The S...

Descripción completa

Detalles Bibliográficos
Autores principales: Rydén, L., Loman, N., Larsson, C., Hegardt, C., Vallon‐Christersson, J., Malmberg, M., Lindman, H., Ehinger, A., Saal, L. H., Borg, Å.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817401/
https://www.ncbi.nlm.nih.gov/pubmed/29341157
http://dx.doi.org/10.1002/bjs.10741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817401/
https://www.ncbi.nlm.nih.gov/pubmed/29341157
http://dx.doi.org/10.1002/bjs.10741

Ejemplares similares